Revolution Medicines · 1 month ago
National Account Director, Academic/IDN Oncology
United States
Full-time
Remote
Director/Executive
$194K/yr - $242K/yr
10+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The National Account Director will be responsible for establishing strategic relationships to secure market access for oncology medicines within large health systems and integrated delivery networks, while leading cross-functional efforts to ensure product inclusion in clinical pathways.
Health CareLife ScienceMedical
Responsibilities
Translate national, brand-level strategy to targeted Large Health Systems, IDNs and key KOL/Pharmacy decision makers
Lead and oversee account activities such as driving rapid formulary, clinical pathway and treatment protocol inclusion post launch in close collaboration with Medical Affairs
Lead all Business to Business and C-Suite relationships with key accounts to support speaker programs, access activities, networking events, and company partnerships
Build and maintain strong KOL and C-level relationships with aligned IDN and large system accounts
Lead cross-functional team across Commercial Field to pro-actively identify and resolve access barrier issues
Analyze business opportunities to proactively provide strategic and tactical guidance
Negotiate favorable contracts and agreements
Create medium to long term strategic engagement plan spanning multiple product and indication launches and focuses on engaging beyond transactional approaches
Facilitate executive exchanges to create opportunities for Rev Med leaders and IDN/C-Suite leaders to meet and align
Identify the overlap between customer needs and Rev Med needs to build collaborative business solutions
Champion voice of customer to internal stakeholders and commercial leadership
Consistently strong appropriate engagement with IDN pharmacy leadership and formulary decision makers
Provide strategic insights and feedback to brands, field, and market access
Quickly communicate when important opportunities arise
Activate resources to support opportunities and challenges
Ability to design and lead pull through projects with commercial field
Conduct quarterly business reviews with key systems and internal stakeholders
Track and analyze account performance and identify areas for improvement
Qualification
Required
Bachelor's degree and 10+ years strategic account management experience
Strong established relationships within IDN/Academic Centers, Pharmacy, C-suite and Key KOL stakeholders
Demonstrated understanding of reimbursement, economic flows, and oral oncolytic trends within health systems and key customer stakeholders
Strong communication skills to educate and influence other stakeholders, including the commercial executive leadership team and US Market Access
Ability to clearly and efficiently communicate the value proposition of novel oncology therapies to customers
Excellent negotiation skills and pride in P&L and enterprise stewardship
Prior experience with pipeline products and product launches
Ability to partner effectively with Medical Affairs, Sales, Marketing and FRM teams
Strategic account planning and strong business acumen
50% travel required to customer meetings, industry conferences, and Rev Med's home office in Redwood City, CA
Preferred
Advanced degree (MBA, Master's, PharmD, PhD)
Existing relationships within the IDN/ academic oncology segment and key pharmacy/ KOLs stakeholders within the segment
Comprehensive experience and understanding Large Health Systems/IDNs and the Hospital class of trade
Experience in GI oncology, PDAC and/or NSCLC, including oral targeted therapies
Successful coordination of leadership exchanges and strategic partnerships beyond traditional contracting and rebate agreements
Previous direct experience with contract negotiation, implementation and pull through
Desire to continuously learn, develop, and stay abreast of the evolving healthcare landscape
Passion for establishing high-functioning, collaborative relationships with new and rapidly growing teams
Prior people leadership experience and ability to build team as company grows
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase